• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症一种休克发生率和死亡率较高的亚表型中脂质代谢失调的多组学分子模式。

Multiomic molecular patterns of lipid dysregulation in a subphenotype of sepsis with higher shock incidence and mortality.

作者信息

Augustin Beulah, Wu Dongyuan, Black Lauren Page, Bertrand Andrew, Sulaiman Dawoud, Hopson Charlotte, Jacob Vinitha, Shavit Jordan A, Hofmaenner Daniel A, Labilloy Guillaume, Smith Leslie, Cagmat Emilio, Graim Kiley, Datta Susmita, Reddy Srinivasa T, Guirgis Faheem W

机构信息

Department of Emergency Medicine, University of Florida College of Medicine, 1329 SW 16thStreet, Gainesville, FL, 32610, USA.

Department of Biostatistics, University of Florida, Gainesville, FL, USA.

出版信息

Crit Care. 2024 Dec 24;28(1):431. doi: 10.1186/s13054-024-05216-3.

DOI:10.1186/s13054-024-05216-3
PMID:39716214
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11667828/
Abstract

BACKGROUND

Lipids play a critical role in defense against sepsis. We sought to investigate gene expression and lipidomic patterns of lipid dysregulation in sepsis.

METHODS

Data from four adult sepsis studies were analyzed and findings were investigated in two external datasets. Previously characterized lipid dysregulation subphenotypes of hypolipoprotein (HYPO; low lipoproteins, increased mortality) and normolipoprotein (NORMO; higher lipoproteins, lower mortality) were studied. Leukocytes collected within 24 h of sepsis underwent RNA sequencing (RNAseq) and shotgun plasma lipidomics was performed.

RESULTS

Of 288 included patients, 43% were HYPO and 57% were NORMO. HYPO patients exhibited higher median SOFA scores (9 vs 5, p = < 0.001), vasopressor use (67% vs 34%, p = < 0.001), and 28-day mortality (30% vs 16%, p = 0.004). Leukocyte RNAseq identified seven upregulated lipid metabolism genes in HYPO (PCSK9, DHCR7, LDLR, ALOX5, PLTP, FDFT1, and MSMO1) vs. NORMO patients. Lipidomics revealed lower cholesterol esters (CE, adjusted p = < 0.001), lysophosphatidylcholines (LPC, adjusted p = 0.001), and sphingomyelins (SM, adjusted p = < 0.001) in HYPO patients. In HYPO patients, DHCR7 expression strongly correlated with reductions in CE, LPC, and SM (p < 0.01), while PCSK9, MSMO1, DHCR7, PLTP, and LDLR upregulation were correlated with low LPC (p < 0.05). DHCR7, ALOX5, and LDLR correlated with reductions in SM (p < 0.05). Mortality and phenotype comparisons in two external datasets (N = 824 combined patients) corroborated six of the seven upregulated lipid genes (PCSK9, DHCR7, ALOX5, PLTP, LDLR, and MSMO1).

CONCLUSION

We identified a genetic lipid dysregulation signature characterized by seven lipid metabolism genes. Five genes in HYPO sepsis patients most strongly correlated with low CE, LPC, and SMs that mediate cholesterol storage and innate immunity.

摘要

背景

脂质在脓毒症防御中起关键作用。我们试图研究脓毒症中脂质代谢失调的基因表达和脂质组学模式。

方法

分析了来自四项成人脓毒症研究的数据,并在两个外部数据集中进行了研究。研究了先前已鉴定的低脂蛋白血症(HYPO;低脂蛋白,死亡率增加)和正常脂蛋白血症(NORMO;较高脂蛋白,较低死亡率)的脂质代谢失调亚表型。在脓毒症发生后24小时内收集的白细胞进行RNA测序(RNAseq),并进行鸟枪法血浆脂质组学分析。

结果

在纳入的288例患者中,43%为HYPO,57%为NORMO。HYPO患者的SOFA评分中位数较高(9比5,p = <0.001),血管升压药使用比例较高(67%比34%,p = <0.001),28天死亡率较高(30%比16%,p = 0.004)。白细胞RNAseq鉴定出与NORMO患者相比,HYPO患者中有7个脂质代谢基因上调(PCSK9、DHCR7、LDLR、ALOX5、PLTP、FDFT1和MSMO1)。脂质组学显示HYPO患者的胆固醇酯(CE,校正p = <0.001)、溶血磷脂酰胆碱(LPC,校正p = 0.001)和鞘磷脂(SM,校正p = <0.001)含量较低。在HYPO患者中,DHCR7表达与CE、LPC和SM的降低密切相关(p <0.01),而PCSK9、MSMO1、DHCR7、PLTP和LDLR的上调与低LPC相关(p <0.05)。DHCR7、ALOX5和LDLR与SM的降低相关(p <0.05)。两个外部数据集(共824例患者)的死亡率和表型比较证实了七个上调的脂质基因中的六个(PCSK9、DHCR7、ALOX5、PLTP、LDLR和MSMO1)。

结论

我们鉴定出一个以七个脂质代谢基因特征的遗传脂质代谢失调特征。HYPO脓毒症患者中的五个基因与介导胆固醇储存和先天免疫的低CE、LPC和SMs最密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/11667828/e08ceaf4f413/13054_2024_5216_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/11667828/bac16c8fbb9a/13054_2024_5216_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/11667828/56edfbae8e17/13054_2024_5216_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/11667828/61f60ad42842/13054_2024_5216_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/11667828/e08ceaf4f413/13054_2024_5216_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/11667828/bac16c8fbb9a/13054_2024_5216_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/11667828/56edfbae8e17/13054_2024_5216_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/11667828/61f60ad42842/13054_2024_5216_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/11667828/e08ceaf4f413/13054_2024_5216_Fig4_HTML.jpg

相似文献

1
Multiomic molecular patterns of lipid dysregulation in a subphenotype of sepsis with higher shock incidence and mortality.脓毒症一种休克发生率和死亡率较高的亚表型中脂质代谢失调的多组学分子模式。
Crit Care. 2024 Dec 24;28(1):431. doi: 10.1186/s13054-024-05216-3.
2
IDENTIFYING A SEPSIS SUBPHENOTYPE CHARACTERIZED BY DYSREGULATED LIPOPROTEIN METABOLISM USING A SIMPLIFIED CLINICAL DATA ALGORITHM.使用简化临床数据算法识别以脂蛋白代谢失调为特征的脓毒症亚表型
Shock. 2025 Aug 1;64(2):218-225. doi: 10.1097/SHK.0000000000002605. Epub 2025 Apr 23.
3
Functional immune profiling of hyper- and hypo-inflammatory subphenotypes of critical illness: a secondary analysis.危重症高炎症和低炎症亚表型的功能性免疫谱分析:一项二次分析
Front Immunol. 2025 May 9;16:1520848. doi: 10.3389/fimmu.2025.1520848. eCollection 2025.
4
Expression Predicts Poor Outcomes and Mortality From Sepsis.表达可预测脓毒症的不良预后和死亡率。
Crit Care Explor. 2023 Jun 14;5(6):e0929. doi: 10.1097/CCE.0000000000000929. eCollection 2023 Jun.
5
Untargeted lipidomics profiling provides novel insights into pediatric patients with sepsis: an exploratory study.非靶向脂质组学分析为脓毒症患儿提供了新见解:一项探索性研究。
Metabolomics. 2025 Apr 26;21(3):59. doi: 10.1007/s11306-025-02255-x.
6
Molecular Phenotyping of Sepsis and Differential Response to Fluid Resuscitation.脓毒症的分子表型分析及对液体复苏的差异反应
Am J Respir Crit Care Med. 2025 Sep;211(9):1681-1688. doi: 10.1164/rccm.202412-2377OC.
7
Assessment of S100A8/A9 and resistin as predictive biomarkers for mortality in critically ill patients with sepsis.评估S100A8/A9和抵抗素作为脓毒症重症患者死亡率的预测生物标志物。
Front Cell Infect Microbiol. 2025 Jun 3;15:1555307. doi: 10.3389/fcimb.2025.1555307. eCollection 2025.
8
ROLE OF CHANGES IN LIPOPROTEINS, LIPIDOMES, AND GUT MICROBIOTA IN THE PATHOGENESIS OF PERSISTENT INFLAMMATION, IMMUNOSUPPRESSION, AND CATABOLISM SYNDROME: A PROSPECTIVE COHORT STUDY.脂蛋白、脂质组和肠道微生物群变化在持续性炎症、免疫抑制和分解代谢综合征发病机制中的作用:一项前瞻性队列研究。
Shock. 2025 Sep 1;64(3):322-331. doi: 10.1097/SHK.0000000000002634.
9
PROGNOSTIC IMPLICATIONS OF CHANGES IN PLATELET TRAJECTORIES IN PATIENTS WITH SEPSIS: A RETROSPECTIVE ANALYSIS USING THE MEDICAL INFORMATION MART FOR INTENSIVE CARE IV DATABASE.脓毒症患者血小板轨迹变化的预后意义:一项使用重症监护医学信息数据库IV的回顾性分析
Shock. 2025 Mar 1;63(3):371-378. doi: 10.1097/SHK.0000000000002493. Epub 2024 Oct 10.
10
Enhanced Production of Lipid Mediators in Plasma and Activation of DNA Damage Pathways in PBMCs Are Correlated With the Severity of Ancestral SARS-CoV-2 Infection.血浆中脂质介质的产生增强以及外周血单个核细胞中DNA损伤途径的激活与祖先SARS-CoV-2感染的严重程度相关。
FASEB J. 2025 May 15;39(9):e70600. doi: 10.1096/fj.202403195R.

引用本文的文献

1
The Connections Between Dietary Fatty Acids, Inflammation, and Chronic Disease.膳食脂肪酸、炎症与慢性病之间的联系
Nutrients. 2025 Jul 15;17(14):2322. doi: 10.3390/nu17142322.

本文引用的文献

1
Lipidomic changes in a novel sepsis outcome-based analysis reveals potent pro-inflammatory and pro-resolving signaling lipids.基于新型脓毒症结局分析的脂质组学变化揭示了强效促炎和促修复信号脂质。
Clin Transl Sci. 2024 Mar;17(3):e13745. doi: 10.1111/cts.13745.
2
The Lipid Intensive Drug Therapy for Sepsis Phase II Pilot Clinical Trial.脓毒症二期临床试验中的强化降脂药物治疗
Crit Care Med. 2024 Aug 1;52(8):1183-1193. doi: 10.1097/CCM.0000000000006268. Epub 2024 Mar 15.
3
The Plasma Lipidomic Landscape in Patients with Sepsis due to Community-acquired Pneumonia.
社区获得性肺炎所致脓毒症患者的血浆脂质组学概况
Am J Respir Crit Care Med. 2024 Apr 15;209(8):973-986. doi: 10.1164/rccm.202308-1321OC.
4
Expression Predicts Poor Outcomes and Mortality From Sepsis.表达可预测脓毒症的不良预后和死亡率。
Crit Care Explor. 2023 Jun 14;5(6):e0929. doi: 10.1097/CCE.0000000000000929. eCollection 2023 Jun.
5
Association Between Hypocholesterolemia and Mortality in Critically Ill Patients With Sepsis: A Systematic Review and Meta-Analysis.脓毒症重症患者低胆固醇血症与死亡率之间的关联:一项系统评价和荟萃分析
Crit Care Explor. 2023 Feb 1;5(2):e0860. doi: 10.1097/CCE.0000000000000860. eCollection 2023 Feb.
6
PCSK9 Promotes Endothelial Dysfunction During Sepsis Via the TLR4/MyD88/NF-κB and NLRP3 Pathways.前蛋白转化酶枯草溶菌素9通过Toll样受体4/髓样分化因子88/核因子κB和NLRP3途径促进脓毒症期间的内皮功能障碍。
Inflammation. 2023 Feb;46(1):115-128. doi: 10.1007/s10753-022-01715-z. Epub 2022 Aug 5.
7
Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC.鉴定 FDFT1 为与 ccRCC 中铁死亡相关的潜在生物标志物。
Cancer Med. 2022 Nov;11(21):3993-4004. doi: 10.1002/cam4.4716. Epub 2022 Mar 24.
8
Genetic variants associated with sepsis.与脓毒症相关的遗传变异。
PLoS One. 2022 Mar 11;17(3):e0265052. doi: 10.1371/journal.pone.0265052. eCollection 2022.
9
Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures.预测首发临床症状的脓毒症严重程度:内表型和机制特征的作用。
EBioMedicine. 2022 Jan;75:103776. doi: 10.1016/j.ebiom.2021.103776. Epub 2022 Jan 10.
10
The Many Roles of Cholesterol in Sepsis: A Review.胆固醇在脓毒症中的多种作用:综述。
Am J Respir Crit Care Med. 2022 Feb 15;205(4):388-396. doi: 10.1164/rccm.202105-1197TR.